Makoto Ota
Founder at WELBE, INC.
Net worth: 38 M $ as of 2024-04-29
Profile
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
WELBE,INC.
20.00% | 2024-03-26 | 5,512,154 ( 20.00% ) | 38 M $ | 2024-04-29 |
Makoto Ota active positions
| Companies | Position | Start |
|---|---|---|
| WELBE, INC. | Founder | 2011-11-30 |
| Welbe Healthcare, Inc. | Director/Board Member | 2021-05-31 |
Former positions of Makoto Ota
| Companies | Position | End |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| WELBE, INC. | Commercial Services |
| Private companies | 2 |
|---|---|
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Makoto Ota
